Potential health benefits of bread supplemented with defatted flaxseeds under dietary regimen in normal and type 2 diabetic subjects

Polish Journal of Food and Nutrition Sciences

Volumn 62, Issue 2, 2012, Pages 103-108

  Mohamed, Doha A ^a   Al Okbi, Sahar Y ^a   El Hariri, Dardiri M ^a   Mousa, Ismael I ^b  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b MILITARY MEDICAL ACADEMY   (Egypt)

Author keywords

Anthropometric parameters; Defatted flaxseed bread; Lipid profile; Normal subjects; Type 2 diabetes

Indexed keywords

EID: 84859817129     PISSN: 12300322     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10222-011-0049-x     Document Type: Article

References (44)

1. Al-Shamaony L., Al-Khazraji S.M., Twaij H.A.A., Hypoglycemic effect of Artemisia herba alba. II. Effect of a valuable extract on some blood parameters in diabetic animals. J. Ethnopharm., 1994, 43, 167-171.
2. Amresh G., Kant R., Zeashan H., Gupta R.J., Rao C.H.V., Singh P.N., Gastroprotective effects of ethanolic extract from Cissampelos pareira in experimental animals. J. Nat. Med., 2007, 61, 323-328.
3. Anuradha C.V., Selvam R., Effect of oral methionine on tissue lipid peroxidation and antioxidants in alloxan-induced diabetic rats. J. Nutri. Biochem., 1993, 4, 212-217.
4. Assmann G., Nofer J., Atheroprotective effects of high-density lipoproteins. Ann. Rev. Med., 2003, 54, 321-341.
5. Atwal A.S., Kubow C., Wolynetz M.S., Effect of protein source and amino acid supplementation on plasma cholesterol in guinea pig. Int. J. Vitam. Nutr. Res., 1997, 67, 192-195.
6. Bray G.A., What is the ideal body weight? J. Nutr. Biochem., 1998, 9, 489-492.
7. Burstein M., Scholnick H.R., Morfin R., Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J. Lipid Res., 1970, 11, 583-95.
8. Chung M.W.Y., Isolation and characterization of the major fraction of flaxseed proteins. 2001, MSc. thesis, The University of British Columbia, Vancouver, BC, Canada, p. 75.
9. Duckworth W.C., Hyperglycemia and cardiovascular disease. Curr. Ather. Rep., 2001, 3, 381-391.
10. FAO/WHO. Food and Nutrition Board. Nutritional Research Council. Recommended Dietary Allowances, 1989, 10th ed. Washington DC. National Academy Press.
11. Fukuda Y., Osawa T., Namiki M., Ozaki T., Studies on antioxidative substances in sesame seed. Agric. Biol. Chem., 1985, 49, 301-306.
12. Goldberg I.J., Clinical Review 124. Diabetic dyslipidemia: causes and consequences. J. Clin. Endocr. Met., 2001, 86, 965-971.
13. Gupta A.K., Ross E.A., Myers J.N., Kashyap M.L., Increased reverse cholesterol transport in athletes. Metabolism, 1993, 42, 684-690.
14. Houot O., Interpretation of Clinical Laboratory Tests (eds. G. Siest, J. Henny, F. Schiele, D.S. young). 1985, Biomedical Publications, p. 250.
15. Jenkins D.J., Kendall C.W., Vidgen E., Agarwal S., Rao A.V., Rosenberg R.S., Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measures, and ex vivo androgen and progestin activity: a controlled crossover trial. Am. J. Clin. Nutr., 1999, 69, 395-402.
16. Limaye P.V., Raghuram N., Sivakami S., Oxidative stress and gene expression of antioxidant enzymes in the renal cortex of streptozotocin-induced diabetic rats. Mol. Cell. Biochem., 2003, 243, 147-152.
17. Makni M., Fetoui H., Gargouri N.K., Garoui E.M., Jaber H., Makni J., Boudawara T., Zeghal N., Hypolipidemic and hepatoprotective effects of flax and pumpkin seed mixture rich in omega-3 and omega-6 fatty acids in hypercholesterolemic rats. Food Chem. Toxicol., 2008, 46, 3714-3720.
18. Makni M., SefiM., Fetoui H., Garoui E., Gargouri K.N., Boudawara T., Zeghal N., Flax and pumpkin seeds mixture ameliorates diabetic nephropathy in rats. Food Chem. Toxicol., 2010, 48, 2407-2412.
19. Maritim A.C., Sanders R.A., Watkins J.B., Diabetes, oxidative stress and antioxidants. A review. J. Biochem. Mol. Toxicol., 2003, 17, 24-38.
20. Megraw R.E., Dunn D.E., Biggs H.G., Manual and continuousflow colorimetry of triglycerols by a fully enzymic method. Clin. Chem., 1979, 25, 273-278.
21. Mohamed D.A., El-Hariri D.M., Al-Okbi S.Y., Impact of feeding bread enriched with flaxseed on plasma profile of hyperlipidemic rats. Pol. J. Food Nutr. Sci., 2005, 55, 431-436.
22. Oomah B.D., Mazza G., Bioactive components of flaxseed: occurrence and health benefits. 2000, in: Phytochemicals and Phytopharmaceuticals (eds. F. Shahidi, C.T. Ho). AOCS Press, Champaign, IL., p. 105.
23. Palanduz S., Ademoglu E., Gokkusu C., Plasma antioxidants and type 2 diabetes mellitus. Res. Commun. Mol. Pathol. Pharmacol., 2001, 109, 309-318.
24. Pegklidou K., Nicolaou I., Demopoulos V.J., Nutritional overview on the management of type 2 diabetes and the prevention of its complications. Curr. Diab. Rev., 2010, 6, 400-409.
25. Prasad K., Oxidative stress as a mechanism of diabetes in diabetic BB prone rats: effect of secoisolariciresinol diglucoside (SDG). Mol. Cell Biochem., 2000, 209, 89-96.
26. Prasad K., Secoisolariciresinol diglucoside from flaxseed delays the development of type 2 diabetes in Zucker rat. J. Lab. Clin. Med., 2001, 138, 32-39.
27. Prasad K., Hypocholesterolemic and antiatherosclerotic effect of flax lignan complex isolated from flaxseed. Atherosclerosis, 2005, 179, 269-275.
28. Prasad K., Regression of hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Atherosclerosis, 2008, 197, 34-42.
29. Pszczola D.E., Genes and diet: the specialized role ingredients may play. Food Tech., 2000, 54, 82-88.
30. Reitman S., Frankel S., Colorimetric methods for aspartate and alanine aminotransferase. Am. J. Clin. Pathol., 1957, 28, 55-60.
31. Rhoads G.G., Gulbrandsen C.L., Kagan A., Serum lipoproteins and coronary artery disease in a population study of Hawaiian Japanese men. New Engl. J. Med., 1976, 294, 293-298.
32. Satoh K., Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin. Chim. Acta, 1978, 90, 37-43.
33. 2. J. Clin. Chem. Clin. Biochem, 1984, 22, 35-40.
34. Shah P.K., Kaul S., Nilsson J., Cercek B., Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing in coming. Part I. Circulation, 2001, 104, 2376-2383.
35. Simopoulos A.P., Omega-3 fatty acids in health and disease and in growth and development. Am. J. Clin. Nutr., 1991, 54, 438-463.
36. Stolar M., Addressing cardiovascular risk in patients with type 2 diabetes: focus on primary care. Am. J. Med. Sci., 2011, 341, 132-140.
37. Thompson P.D., Cullinane E.M., Sady S.P., Contrasting effects of testosterone and stanozolol on serum lipoprotein levels. JAMA., 1989, 261, 1165-1168.
38. Toro G., Ackerman P.G., Practical Clinical Chemistry, 1st edition, Little, Brown and Company, Boston USA; 1975, 352-359.
39. Trinder P., Determination of glucose in blood using an oxidaseperoxidase system with a non-carcinogenic chromogen. J. Clin. Path., 1969, 22, 158-161.
40. Ugochukwu N.H., Babady N.E., Cobourne M., Gasset S.R., The effect of Gongronema latifolium extracts on serum lipid profile and oxidative stress in hepatocytes of diabetic rats. J. Biosci., 2003, 28, 1-5.
41. Vijaimohan K., Jainu M., Sabitha K.E., Subramaniyam S., Anandhan C., Shyamala Devi C.S., Beneficial effects of alpha linolenic acid rich flaxseed oil on growth performance and hepatic cholesterol metabolism in high fat diet fed rats. Life Sci., 2006, 79, 448-454.
42. Watson D., A simple method for the determination of serum cholesterol. Clin. Chim. Acta, 1960, 5, 637-642.
43. Whitmore C., Type 2 diabetes and obesity in adults. Br. J. Nurs., 2010, 19, 880, 882-886.
44. Young I.S., Lipids for psychiatrists - an overview. J. Psychopharmacol., 2005, 19, 6 Suppl., 66-75.